European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Resistant Starch Intake Facilitates Weight Loss in Humans by Reshaping the Gut Microbiota April 11, 2025 Researchers Examine Prebiotic Supplementation in Kidney Transplant Patients to Mitigate infection and GI Upset April 5, 2022 Effect of Prebiotic Yeast Mannan on Gut Health and Sleep Quality January 5, 2024
Resistant Starch Intake Facilitates Weight Loss in Humans by Reshaping the Gut Microbiota April 11, 2025
Researchers Examine Prebiotic Supplementation in Kidney Transplant Patients to Mitigate infection and GI Upset April 5, 2022